Pharmafocus - Clinical studies still not being published

Half of all trials registered on a US clinical study database are not being published in public journals.This is according to a new report from Thomson Reuters Cortellis Clinical Trials, which found that of 600 studies chosen randomly from Clinicaltrials.gov - only 50% had their results published in a journal.ClinicalTrials.gov is the main registry and results database of publicly and privately supported clinical studies of human drug trials conducted around the world. The report called ‘Developments in Clinical Trials’, notes that lack or ambiguity in reporting clinical outcome achievement “could potentially be detrimental to clinical healthcare improvements”.It also found that some of the trials taking place today not only go unpublished, but also unregistered. “This might reduce a patient’s potential to find a suitable treatment, as well as lower the capability of the trial to include an appropriate and representative patient cohort,” the authors say.This comes at a difficult time for the industry as in Europe new rules by both the European Medicines Agency and the European Parliament are set to be debated over the coming weeks.In fact on 3 April the Parliament is set to approve a new directive that will require anyone running a clinical trial to register it and publish a summary of results in a publicly accessible EU database.Currently these types of data are stored on a database that can only be accessed by the EMA. On top of this, full ...
Source: PharmaGossip - Category: Pharma Commentators Authors: Source Type: blogs